Novadiscovery Company
novadiscovery is a developer of a drug discovery platform in silico clinical trials designed to de-risk, optimize research and development along with curbing the cost of discovering new drugs. The company's platform uses mathematics and intelligent algorithms to build a community of virtual patients as on-demand digital lab rats, enabling scientists and biotech, pharma companies to predict drug efficacy and create the target combination.
.png)
.png)
Technology:
Artificial Intelligence, Biotechnology, CRM, Health Care, Information Technology, Medical
Industry:
Data Processing, Clinical Development
Headquarters:
Lyon, Rhone-Alpes, France
Founded Date:
2010-01-01
Employees Number:
11-50
Funding Status:
Early Stage Venture
Investors Number:
4
Total Funding:
8576734
Estimated Revenue:
Less than $1M
Last Funding Date:
2021-02-16
Last Funding Type:
Series A
Register and Claim Ownership